DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR TOPOTECAN HYDROCHLORIDE
Clinical Trials for Topotecan Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00001333 | Phase I Study of Intrathecal Topotecan | Completed | National Cancer Institute (NCI) | Phase 1 | The purpose of this study is to determine the qualitative and quantitative toxicity of intrathecal topotecan, a topoisomerase I inhibitor, in patients with meningeal malignancies refractory to conventional therapy (radiation therapy and chemotherapy). |
| NCT00002395 | Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML) | Completed | SmithKline Beecham | Phase 2 | The purpose of this study is to see if it is safe and effective to give topotecan through a vein to treat HIV-infected patients with PML, an opportunistic (AIDS-related) infection caused by a virus that infects brain tissue and causes damage to the brain and the spinal cord. Topotecan fights HIV and the JC virus (the virus that causes PML) in laboratory experiments. |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | Completed | Memorial Sloan Kettering Cancer Center | Phase 2 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with thiotepa, carboplatin, and topotecan followed by bone marrow transplantation in treating patients who have metastatic or progressive rare cancer. |
| NCT00002537 | Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | Phase I trial to study the effectiveness of radiation therapy plus topotecan in treating patients who have non-small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy and radiation therapy may kill more tumor cells. |
| NCT00002587 | Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors | Completed | National Cancer Institute (NCI) | Phase 1 | Phase I trial to study the effectiveness of paclitaxel plus topotecan in treating patients who have solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. |
| NCT00002588 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | Completed | National Cancer Institute (NCI) | Phase 1 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of topotecan and etoposide in treating patients who have recurrent or refractory leukemia. |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Topotecan Hydrochloride
Clinical Trial Locations for Topotecan Hydrochloride
Trials by Country
Clinical Trial Progress for Topotecan Hydrochloride
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Topotecan Hydrochloride
Sponsor Name
